Optiver Holding
NEO icon

Optiver Holding’s NeoGenomics NEO Stock Holding History

Optiver Holding’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Buy
+762
New +$7.35K ﹤0.01% 1715
2025
Q4 		– Sell
-198
Closed -$1.53K – 2799
2025
Q3 		$1.53K Buy
+198
New +$1.39K ﹤0.01% 2448

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Optiver Holding's NEO Position: Q2 2026 in Review

Optiver Holding opened a new position in NeoGenomics (NEO) in Q2 2026: 762 shares worth $11.1K. The stake represents ﹤0.01% of the portfolio and ranks #1715 among its holdings. This is a return to the name: Optiver Holding previously reported a position in NEO as recently as Q3 2025.

Optiver Holding first reported a position in NEO in Q3 2025 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Optiver Holding held 762 shares of NeoGenomics worth $11.1K as of Q2 2026.
  • NeoGenomics was a new Optiver Holding position in Q2 2026.
  • NeoGenomics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1715 holding.
  • Optiver Holding first reported a position in NeoGenomics in Q3 2025 and has held it in 2 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.